Evidence map›Paper›PMID 32218856›Full record

ArticleOncology letters2020

Determination of the optimal detection time of circulating tumor cells for the postoperative monitoring of colorectal cancer.

Tianchen Huang, Cheng Xu, Jianan Xiao, Qingbing Wang, Yanjun Wang, Yong Zhang, Dongxiao Bai, Fuyou Zhou, Xiaoyu Zhao

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Tianchen HuangThe Fourth Department of General Surgery, Anyang Tumor Hospital, Anyang, Henan 455000, P.R. China.
Cheng XuShanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai Zhangjiang Institute of Medical Innovation, Shanghai 201204, P.R. China.
Jianan XiaoThe Fourth Department of General Surgery, Anyang Tumor Hospital, Anyang, Henan 455000, P.R. China.
Qingbing WangThe Fourth Department of General Surgery, Anyang Tumor Hospital, Anyang, Henan 455000, P.R. China.
Yanjun WangThe Fourth Department of General Surgery, Anyang Tumor Hospital, Anyang, Henan 455000, P.R. China.
Yong ZhangThe Fourth Department of General Surgery, Anyang Tumor Hospital, Anyang, Henan 455000, P.R. China.
Dongxiao BaiThe Fourth Department of General Surgery, Anyang Tumor Hospital, Anyang, Henan 455000, P.R. China.
Fuyou ZhouThe Fourth Department of General Surgery, Anyang Tumor Hospital, Anyang, Henan 455000, P.R. China.
Xiaoyu ZhaoShanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai Zhangjiang Institute of Medical Innovation, Shanghai 201204, P.R. China.
Anyang Tumor Hospital · CNShanghai Innovative Research Center of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating tumor cells (CTCs) are widely used in cancer screening and monitoring. The present study focused on investigating the optimal time for the postoperative CTC detection in patients with colorectal cancer (CRC) to obtain more accurate results and facilitate subsequent treatment. By subtraction enrichment immunofluorescence

Indexed as

circulating tumor cellscolorectal cancerpostoperative monitoring

Identifiers

PMID32218856
PMCPMC7068521
OpenAlexW3006555606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.